Afghanistan vs Denmark: HIV/AIDS deaths averted by antiretroviral therapy
Afghanistan
123.58 deaths
in 2024
Denmark
129.29 deaths
in 2024
Afghanistan rank
123rd
Denmark rank
121st
HIV/AIDS deaths averted by antiretroviral therapy over time
- Afghanistan
- Denmark
How they compare
Denmark currently reports 129.29 deaths against 123.58 deaths in Afghanistan, a difference of 5.71 deaths.
Across all 35 years both countries report, Denmark has been ahead every year.
Afghanistan ranks 123rd and Denmark ranks 121st of 157 countries.
Denmark has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Afghanistan | Denmark | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 64.92 deaths | 64.92 deaths | Denmark |
| 2000s | 0.4161 deaths | 230.44 deaths | 230.02 deaths | Denmark |
| 2010s | 58.68 deaths | 196.83 deaths | 138.15 deaths | Denmark |
| 2020s | 108.95 deaths | 141.56 deaths | 32.61 deaths | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Afghanistan or Denmark?
- Denmark, at 129.29 deaths against 123.58 deaths in Afghanistan as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Afghanistan and Denmark?
- 5.71 deaths, with Denmark ahead.
- How many years of comparable data are there for Afghanistan and Denmark?
- 35 years are reported by both, from 1990 to 2024.
- How do Afghanistan and Denmark rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Afghanistan ranks 123rd and Denmark ranks 121st of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.